124 related articles for article (PubMed ID: 38526250)
21. Indoor radon exposure and risk of lung cancer: a nested case-control study in Finland.
Auvinen A; Mäkeläinen I; Hakama M; Castrén O; Pukkala E; Reisbacka H; Rytömaa T
J Natl Cancer Inst; 1996 Jul; 88(14):966-72. PubMed ID: 8667427
[TBL] [Abstract][Full Text] [Related]
22. Residential radon exposure and esophageal cancer. An ecological study from an area with high indoor radon concentration (Galicia, Spain).
Ruano-Ravina A; Aragonés N; Pérez-Ríos M; López-Abente G; Barros-Dios JM
Int J Radiat Biol; 2014 Apr; 90(4):299-305. PubMed ID: 24460133
[TBL] [Abstract][Full Text] [Related]
23. Environmental radon exposure and childhood leukemia.
Tong J; Qin L; Cao Y; Li J; Zhang J; Nie J; An Y
J Toxicol Environ Health B Crit Rev; 2012; 15(5):332-47. PubMed ID: 22852813
[TBL] [Abstract][Full Text] [Related]
24. Incidence of leukemia, lymphoma, and multiple myeloma in Czech uranium miners: a case-cohort study.
Rericha V; Kulich M; Rericha R; Shore DL; Sandler DP
Environ Health Perspect; 2006 Jun; 114(6):818-22. PubMed ID: 16759978
[TBL] [Abstract][Full Text] [Related]
25. Radon as a causative factor in induction of myeloid leukaemia and other cancers.
Henshaw DL; Eatough JP; Richardson RB
Lancet; 1990 Apr; 335(8696):1008-12. PubMed ID: 1970069
[TBL] [Abstract][Full Text] [Related]
26. Estimating the burden of lung cancer in Canada attributed to occupational radon exposure using a novel exposure assessment method.
Ge CB; Kim J; Labrèche F; Heer E; Song C; Arrandale VH; Pahwa M; Peters CE; Demers PA
Int Arch Occup Environ Health; 2020 Oct; 93(7):871-876. PubMed ID: 32232555
[TBL] [Abstract][Full Text] [Related]
27. An updated assessment of radon exposure in Canada.
Chen J; Moir D
Radiat Prot Dosimetry; 2010 Jul; 140(2):166-70. PubMed ID: 20172936
[TBL] [Abstract][Full Text] [Related]
28. Estimation of residential radon exposure and definition of Radon Priority Areas based on expected lung cancer incidence.
Elío J; Crowley Q; Scanlon R; Hodgson J; Zgaga L
Environ Int; 2018 May; 114():69-76. PubMed ID: 29486412
[TBL] [Abstract][Full Text] [Related]
29. Radon exposure and leukaemia in adulthood.
Viel JF
Int J Epidemiol; 1993 Aug; 22(4):627-31. PubMed ID: 8225735
[TBL] [Abstract][Full Text] [Related]
30. Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies.
Darby SC; Whitley E; Howe GR; Hutchings SJ; Kusiak RA; Lubin JH; Morrison HI; Tirmarche M; Tomásek L; Radford EP
J Natl Cancer Inst; 1995 Mar; 87(5):378-84. PubMed ID: 7853419
[TBL] [Abstract][Full Text] [Related]
31. Assessment of thoron contribution to indoor radon exposure in Canada.
Chen J
Radiat Environ Biophys; 2022 Mar; 61(1):161-167. PubMed ID: 34973065
[TBL] [Abstract][Full Text] [Related]
32. Is environmental radon gas associated with the incidence of neurodegenerative conditions? A retrospective study of multiple sclerosis in radon affected areas in England and Wales.
Groves-Kirkby CJ; Denman AR; Campbell J; Crockett RG; Phillips PS; Rogers S
J Environ Radioact; 2016 Apr; 154():1-14. PubMed ID: 26809141
[TBL] [Abstract][Full Text] [Related]
33. Residential radon-222 exposure and lung cancer: exposure assessment methodology.
Field RW; Steck DJ; Lynch CF; Brus CP; Neuberger JS; Kross BC
J Expo Anal Environ Epidemiol; 1996; 6(2):181-95. PubMed ID: 8792296
[TBL] [Abstract][Full Text] [Related]
34. Childhood cancer and residential radon exposure - results of a population-based case-control study in Lower Saxony (Germany).
Kaletsch U; Kaatsch P; Meinert R; Schüz J; Czarwinski R; Michaelis J
Radiat Environ Biophys; 1999 Sep; 38(3):211-5. PubMed ID: 10525959
[TBL] [Abstract][Full Text] [Related]
35. A combined analysis of North American case-control studies of residential radon and lung cancer.
Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Field RW; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
J Toxicol Environ Health A; 2006 Apr; 69(7):533-97. PubMed ID: 16608828
[TBL] [Abstract][Full Text] [Related]
36. Utility gains from reductions in the modifiable burden of lung cancer attributable to residential radon in Canada.
Gaskin J; Coyle D; Whyte J; Krewski D
Can J Public Health; 2018 Aug; 109(4):598-609. PubMed ID: 30264193
[TBL] [Abstract][Full Text] [Related]
37. INDOOR RADON (222RN) MEASUREMENTS AND ESTIMATION OF ANNUAL EFFECTIVE DOSE IN MVANGAN LOCALITY, SOUTH CAMEROON.
Akamba Mbembe B; Manga A; Mbida Mbembe S; Ele Abiama P; Saidou ; Ondo Meye P; Kofane TC; Ben-Bolie GH
Radiat Prot Dosimetry; 2022 Dec; 198(20):1565-1574. PubMed ID: 36274266
[TBL] [Abstract][Full Text] [Related]
38. Results of simultaneous radon and thoron measurements in 33 metropolitan areas of Canada.
Chen J; Bergman L; Falcomer R; Whyte J
Radiat Prot Dosimetry; 2015 Feb; 163(2):210-6. PubMed ID: 24748485
[TBL] [Abstract][Full Text] [Related]
39. Population attributable risk associated with lung cancer induced by residential radon in Canada: Sensitivity to relative risk model and radon probability density function choices: In memory of Professor Jan M. Zielinski.
Al-Arydah M
Sci Total Environ; 2017 Oct; 596-597():331-341. PubMed ID: 28437651
[TBL] [Abstract][Full Text] [Related]
40. An overview of the North American residential radon and lung cancer case-control studies.
Field RW; Krewski D; Lubin JH; Zielinski JM; Alavanja M; Catalan VS; Klotz JB; Létourneau EG; Lynch CF; Lyon JL; Sandler DP; Schoenberg JB; Steck DJ; Stolwijk JA; Weinberg C; Wilcox HB
J Toxicol Environ Health A; 2006 Apr; 69(7):599-631. PubMed ID: 16608829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
